Elevated expression of proto-oncogenes during interleukin-5-induced growth and differentiation of murine B lineage cells. 1990

M Migita, and N Yamaguchi, and S Katoh, and S Mita, and R Matsumoto, and E Sonoda, and H Tsuchiya, and I Matsuda, and A Tominaga, and K Takatsu
Department of Biology, Kumamoto University Medical School.

Interleukin 5 (IL-5), a lymphokine produced by helper T cells, is involved in the regulation of growth and differentiation of B cells and other hematopoietic cells. To elucidate IL-5-mediated intracellular mechanisms, we have established IL-5-dependent and -independent murine early B cell lines, J6 and MJ88-1, respectively, and examined the effect of IL-5 on the expression of proto-oncogenes during proliferation. Two- to 3.5-fold increases in the levels of c-myb, c-myc, c-fos, and c-fms mRNA were observed in J6 cells, compared with those in MJ88-1 cells. Further, a role of IL-5 in the proto-oncogene expression during differentiation was examined by using thymidine-treated murine B-cell chronic leukemia BCL1-B20 cells with growth arrest. After 4-day culture, the amount of IgM secreted from BCL1-B20 cells was augmented 4-6 fold in the presence of IL-5. Although expression of c-myb, c-fos, and c-fms mRNA did not change, only c-myc mRNA expression was elevated within 30 min of stimulation with IL-5 and reached a maximal level by 1 hr. Addition of phorbol 12-myristate 13-acetate (PMA) or IL-4 to the culture of BCL1-B20 cells inhibited both the IL-5-mediated augmentation of IgM secretion and the elevated expression of c-myc mRNA. These findings suggest that the IL-5 signal may be associated with the up-regulation of c-myc expression.

UI MeSH Term Description Entries
D007075 Immunoglobulin M A class of immunoglobulin bearing mu chains (IMMUNOGLOBULIN MU-CHAINS). IgM can fix COMPLEMENT. The name comes from its high molecular weight and originally was called a macroglobulin. Gamma Globulin, 19S,IgM,IgM Antibody,IgM1,IgM2,19S Gamma Globulin,Antibody, IgM
D007700 Kinetics The rate dynamics in chemical or physical systems.
D007938 Leukemia A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006) Leucocythaemia,Leucocythemia,Leucocythaemias,Leucocythemias,Leukemias
D008815 Mice, Inbred Strains Genetically identical individuals developed from brother and sister matings which have been carried out for twenty or more generations, or by parent x offspring matings carried out with certain restrictions. All animals within an inbred strain trace back to a common ancestor in the twentieth generation. Inbred Mouse Strains,Inbred Strain of Mice,Inbred Strain of Mouse,Inbred Strains of Mice,Mouse, Inbred Strain,Inbred Mouse Strain,Mouse Inbred Strain,Mouse Inbred Strains,Mouse Strain, Inbred,Mouse Strains, Inbred,Strain, Inbred Mouse,Strains, Inbred Mouse
D011519 Proto-Oncogenes Normal cellular genes homologous to viral oncogenes. The products of proto-oncogenes are important regulators of biological processes and appear to be involved in the events that serve to maintain the ordered procession through the cell cycle. Proto-oncogenes have names of the form c-onc. Proto-Oncogene,Proto Oncogene,Proto Oncogenes
D002471 Cell Transformation, Neoplastic Cell changes manifested by escape from control mechanisms, increased growth potential, alterations in the cell surface, karyotypic abnormalities, morphological and biochemical deviations from the norm, and other attributes conferring the ability to invade, metastasize, and kill. Neoplastic Transformation, Cell,Neoplastic Cell Transformation,Transformation, Neoplastic Cell,Tumorigenic Transformation,Cell Neoplastic Transformation,Cell Neoplastic Transformations,Cell Transformations, Neoplastic,Neoplastic Cell Transformations,Neoplastic Transformations, Cell,Transformation, Cell Neoplastic,Transformation, Tumorigenic,Transformations, Cell Neoplastic,Transformations, Neoplastic Cell,Transformations, Tumorigenic,Tumorigenic Transformations
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D005260 Female Females
D005786 Gene Expression Regulation Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control (induction or repression) of gene action at the level of transcription or translation. Gene Action Regulation,Regulation of Gene Expression,Expression Regulation, Gene,Regulation, Gene Action,Regulation, Gene Expression
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

M Migita, and N Yamaguchi, and S Katoh, and S Mita, and R Matsumoto, and E Sonoda, and H Tsuchiya, and I Matsuda, and A Tominaga, and K Takatsu
September 2021, International journal of molecular sciences,
M Migita, and N Yamaguchi, and S Katoh, and S Mita, and R Matsumoto, and E Sonoda, and H Tsuchiya, and I Matsuda, and A Tominaga, and K Takatsu
January 1984, Nature,
M Migita, and N Yamaguchi, and S Katoh, and S Mita, and R Matsumoto, and E Sonoda, and H Tsuchiya, and I Matsuda, and A Tominaga, and K Takatsu
January 1986, Current topics in microbiology and immunology,
M Migita, and N Yamaguchi, and S Katoh, and S Mita, and R Matsumoto, and E Sonoda, and H Tsuchiya, and I Matsuda, and A Tominaga, and K Takatsu
March 1986, Biochemical and biophysical research communications,
M Migita, and N Yamaguchi, and S Katoh, and S Mita, and R Matsumoto, and E Sonoda, and H Tsuchiya, and I Matsuda, and A Tominaga, and K Takatsu
June 1994, Oncogene,
M Migita, and N Yamaguchi, and S Katoh, and S Mita, and R Matsumoto, and E Sonoda, and H Tsuchiya, and I Matsuda, and A Tominaga, and K Takatsu
January 1999, Molekuliarnaia biologiia,
M Migita, and N Yamaguchi, and S Katoh, and S Mita, and R Matsumoto, and E Sonoda, and H Tsuchiya, and I Matsuda, and A Tominaga, and K Takatsu
January 1993, In vivo (Athens, Greece),
M Migita, and N Yamaguchi, and S Katoh, and S Mita, and R Matsumoto, and E Sonoda, and H Tsuchiya, and I Matsuda, and A Tominaga, and K Takatsu
November 1989, Journal of biochemistry,
M Migita, and N Yamaguchi, and S Katoh, and S Mita, and R Matsumoto, and E Sonoda, and H Tsuchiya, and I Matsuda, and A Tominaga, and K Takatsu
January 1992, American journal of reproductive immunology (New York, N.Y. : 1989),
M Migita, and N Yamaguchi, and S Katoh, and S Mita, and R Matsumoto, and E Sonoda, and H Tsuchiya, and I Matsuda, and A Tominaga, and K Takatsu
January 1989, Annals of the New York Academy of Sciences,
Copied contents to your clipboard!